sb 203580 has been researched along with Nerve Degeneration in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tapia, R; Tovar-Y-Romo, LB | 1 |
| Ganesh Kumar, N; Hosmane, S; Rajbhandari, L; Tegenge, MA; Thakor, N; Uapinyoying, P; Venkatesan, A | 1 |
| Corcoran, ME; Ji, SP; Jiang, W; Saucier, DM; Sheerin, AH; Van Cleemput, J; Zhang, X; Zhang, Y | 1 |
| dela Cruz, VF; Dewil, M; Robberecht, W; Van Den Bosch, L | 1 |
| Bales, KR; Bymaster, FP; Chernet, E; Dodel, RC; Du, Y; Gao, F; Lin, S; Luecke, S; Ma, Z; Nelson, DL; Paul, SM; Perry, KW; Phebus, LA; Triarhou, LC | 1 |
5 other study(ies) available for sb 203580 and Nerve Degeneration
| Article | Year |
|---|---|
VEGF protects spinal motor neurons against chronic excitotoxic degeneration in vivo by activation of PI3-K pathway and inhibition of p38MAPK.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analysis of Variance; Animals; Choline O-Acetyltransferase; Chromones; Cinnamates; Disease Models, Animal; Drug Interactions; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Glial Fibrillary Acidic Protein; Imidazoles; Infusion Pumps, Implantable; Male; Morpholines; Motor Activity; Motor Neurons; Nerve Degeneration; Neurotoxicity Syndromes; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Pyridines; Rats; Rats, Wistar; Spinal Cord; Time Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2010 |
Toll/interleukin-1 receptor domain-containing adapter inducing interferon-β mediates microglial phagocytosis of degenerating axons.
Topics: Adaptor Proteins, Vesicular Transport; Adenosine Triphosphate; Analysis of Variance; Animals; Animals, Newborn; Axons; Axotomy; CD11b Antigen; Cells, Cultured; Chemokine CXCL10; Coculture Techniques; Disease Models, Animal; Embryo, Mammalian; Enzyme Inhibitors; Ganglia, Spinal; Gene Expression Regulation; Hippocampus; Humans; Imidazoles; Interferon-beta; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Mice, Knockout; Microarray Analysis; Microfluidic Analytical Techniques; Microglia; Nerve Degeneration; Neurons; Nitric Oxide; Peptides; Phagocytosis; Pyridines; Quaternary Ammonium Compounds; Rats; Rats, Sprague-Dawley; Receptors, Interleukin-1; Time Factors; Transfection | 2012 |
Involvement of extracellular regulated kinase and p38 kinase in hippocampal seizure tolerance.
Topics: Animals; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Hippocampus; Imidazoles; Male; MAP Kinase Signaling System; Nerve Degeneration; Neurons; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Rats, Inbred F344; Status Epilepticus | 2005 |
Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death.
Topics: Amyotrophic Lateral Sclerosis; Animals; Anti-Inflammatory Agents, Non-Steroidal; Axons; Cell Death; Cell Survival; Enzyme Activation; Enzyme Inhibitors; Hydrazones; Imidazoles; Mice; Mice, Transgenic; Motor Neurons; Mutation; Nerve Degeneration; Neuroprotective Agents; p38 Mitogen-Activated Protein Kinases; Pyridines; Superoxide Dismutase | 2007 |
Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.
Topics: Animals; Caspase 1; Cells, Cultured; Dopamine; Humans; Imidazoles; Male; Mice; Mice, Inbred C57BL; Minocycline; Mitogen-Activated Protein Kinases; Monoamine Oxidase; MPTP Poisoning; Nerve Degeneration; Neurons; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Parkinsonian Disorders; Phosphorylation; Pyridines; Visual Cortex | 2001 |